Page 15 - Kidney Cancer Research Network of Canada (KCRNC) consensus statement on the role of cytoreductive nephrectomy for patients with metastatic renal cell carcinoma

CUAJ – Consensus Statement Mason et al
KCRNC consensus: Cytoreductive nephrectomy for mRCC

Cell Carcinoma Database Consortium (IMDC). Genitourinary Cancer Symposium
20182018.
55. Gershman B, Thompson RH, Moreira DM, Boorjian SA, Lohse CM, Costello
BA, et al. Lymph Node Dissection is Not Associated with Improved Survival
among Patients Undergoing Cytoreductive Nephrectomy for Metastatic Renal
Cell Carcinoma: A Propensity Score Based Analysis. J Urol. 2017;197:574-9.
56. Faiena I, Salmasi A, Lenis AT, Donin NM, Johnson DC, Bachour K, et al.
Overall survival in patients with metastatic renal cell carcinoma and clinical N1
disease undergoing cytoreductive nephrectomy and lymph node dissection. Urol.
2017;02:02.
57. Chipollini J, Abel EJ, Peyton CC, Boulware DC, Karam JA, Margulis V, et al.
Pathologic Predictors of Survival During Lymph Node Dissection for Metastatic
Renal-Cell Carcinoma: Results From a Multicenter Collaboration. Clin
Genitourin Cancer. 2017;17:17.
58. Patel HD, Gorin MA, Gupta N, Kates M, Johnson MH, Pierorazio PM, et al.
Mortality trends and the impact of lymphadenectomy on survival for renal cell
carcinoma patients with distant metastasis. Can Urol Assoc J. 2016;10:389-95.
59. Feuerstein MA, Kent M, Bernstein M, Russo P. Lymph node dissection during
cytoreductive nephrectomy: a retrospective analysis. Int J Urol. 2014;21:874-9.
60. Bhindi B, Wallis CJD, Boorjian SA, Thompson RH, Farrell A, Kim SP, et al. The
Role of Lymph Node Dissection in the Management of Renal Cell Carcinoma: A
Systematic Review and Meta-Analysis. BJU Int. 2018.
61. Barbastefano J, Garcia JA, Elson P, Wood LS, Lane BR, Dreicer R, et al.
Association of percentage of tumour burden removed with debulking
nephrectomy and progression-free survival in patients with metastatic renal cell
carcinoma treated with vascular endothelial growth factor-targeted therapy. BJU
Int. 2010;106:1266-9.
62. Rabets JC, Kaouk J, Fergany A, Finelli A, Gill IS, Novick AC. Laparoscopic
versus open cytoreductive nephrectomy for metastatic renal cell carcinoma.
Urology. 2004;64:930-4.
63. Nunez Bragayrac L, Hoffmeyer J, Abbotoy D, Attwood K, Kauffman E, Spiess P,
et al. Minimally invasive cytoreductive nephrectomy: a multi-institutional
experience. World J Urol. 2016;34:1651-6.
64. Matin SF, Madsen LT, Wood CG. Laparoscopic cytoreductive nephrectomy: the
M. D. Anderson Cancer Center experience. Urology. 2006;68:528-32.
65. Ganeshappa A, Sundaram C, Lerner MA, Gardner TA. Role of the laparoscopic
approach to cytoreductive nephrectomy in metastatic renal-cell carcinoma: does
size matter? J Endourol. 2010;24:1289-92.